Comparative Analysis of Quantitative Indicators of Progesterone Receptor Protein and mRNA Expression in Tumor Cell Lines.

IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
I P Romanov, T A Bogush, A A Alimov, A Y Kuzevanova, A M Scherbakov, V S Kosorukov
{"title":"Comparative Analysis of Quantitative Indicators of Progesterone Receptor Protein and mRNA Expression in Tumor Cell Lines.","authors":"I P Romanov, T A Bogush, A A Alimov, A Y Kuzevanova, A M Scherbakov, V S Kosorukov","doi":"10.1007/s10517-025-06448-1","DOIUrl":null,"url":null,"abstract":"<p><p>Progesterone receptors are involved in the regulation of tumor cell proliferation and therefore can be considered as a target of antitumor drugs. However, the question of the concordance of quantitative indicators of the protein and mRNA produced as a result of the expression of a single gene remains open. In this study, the concordance of the expression of the progesterone receptor protein and mRNA was evaluated using real-time PCR and flow cytometry, respectively, in 10 tumor cell lines (T47D, A375, PANC-1, SNU-1, HT-29, OVCAR-3, BXPC-3, HCC1954, A549, MCF-7). The expression of the progesterone receptor protein was detected in all studied cell lines; the expression of progesterone receptor mRNA was detected only in the T47D, which shows the discordance of these indicators and queries the relevance of measuring the expression of tumor marker mRNA when selecting the targeted anti-tumor drugs for the treatment of oncological diseases.</p>","PeriodicalId":9331,"journal":{"name":"Bulletin of Experimental Biology and Medicine","volume":" ","pages":"141-146"},"PeriodicalIF":0.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of Experimental Biology and Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10517-025-06448-1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/19 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Progesterone receptors are involved in the regulation of tumor cell proliferation and therefore can be considered as a target of antitumor drugs. However, the question of the concordance of quantitative indicators of the protein and mRNA produced as a result of the expression of a single gene remains open. In this study, the concordance of the expression of the progesterone receptor protein and mRNA was evaluated using real-time PCR and flow cytometry, respectively, in 10 tumor cell lines (T47D, A375, PANC-1, SNU-1, HT-29, OVCAR-3, BXPC-3, HCC1954, A549, MCF-7). The expression of the progesterone receptor protein was detected in all studied cell lines; the expression of progesterone receptor mRNA was detected only in the T47D, which shows the discordance of these indicators and queries the relevance of measuring the expression of tumor marker mRNA when selecting the targeted anti-tumor drugs for the treatment of oncological diseases.

肿瘤细胞系孕酮受体蛋白及mRNA表达定量指标的比较分析。
孕激素受体参与肿瘤细胞增殖的调控,因此可以被认为是抗肿瘤药物的靶点。然而,由于单个基因的表达而产生的蛋白质和mRNA的定量指标的一致性问题仍然是开放的。本研究分别采用实时荧光定量PCR和流式细胞术检测10个肿瘤细胞系(T47D、A375、PANC-1、su -1、HT-29、OVCAR-3、BXPC-3、HCC1954、A549、MCF-7)中孕酮受体蛋白和mRNA表达的一致性。所有细胞系均检测到孕激素受体蛋白的表达;孕激素受体mRNA的表达仅在T47D中检测到,说明这些指标的不一致性,质疑在选择肿瘤疾病的靶向抗肿瘤药物时测量肿瘤标志物mRNA表达的相关性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bulletin of Experimental Biology and Medicine
Bulletin of Experimental Biology and Medicine 医学-医学:研究与实验
CiteScore
1.50
自引率
14.30%
发文量
265
审稿时长
2 months
期刊介绍: Bulletin of Experimental Biology and Medicine presents original peer reviewed research papers and brief reports on priority new research results in physiology, biochemistry, biophysics, pharmacology, immunology, microbiology, genetics, oncology, etc. Novel trends in science are covered in new sections of the journal - Biogerontology and Human Ecology - that first appeared in 2005. World scientific interest in stem cells prompted inclusion into Bulletin of Experimental Biology and Medicine a quarterly scientific journal Cell Technologies in Biology and Medicine (a new Russian Academy of Medical Sciences publication since 2005). It publishes only original papers from the leading research institutions on molecular biology of stem and progenitor cells, stem cell as the basis of gene therapy, molecular language of cell-to-cell communication, cytokines, chemokines, growth and other factors, pilot projects on clinical use of stem and progenitor cells. The Russian Volume Year is published in English from April.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信